PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-212.24%
Negative net income growth while CSIQ stands at 158.41%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
23.02%
D&A growth of 23.02% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
234.21%
Deferred tax of 234.21% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
7.24%
SBC growth of 7.24% while CSIQ is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-3243.32%
Negative yoy working capital usage while CSIQ is 36.36%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-63.45%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
58.57%
Inventory growth of 58.57% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-248.28%
Negative yoy AP while CSIQ is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-396.81%
Negative yoy usage while CSIQ is 36.36%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-1274.77%
Negative yoy while CSIQ is 126.30%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-459.13%
Negative yoy CFO while CSIQ is 171.37%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-29.72%
Both yoy lines negative, with CSIQ at -1.91%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
100.00%
Acquisition growth of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
100.00%
Purchases growth of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-100.00%
We reduce yoy sales while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
62.93%
Growth well above CSIQ's 33.39%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
81.13%
Investing outflow well above CSIQ's 4.41%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.46%
We have some buyback growth while CSIQ is negative at -13.16%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.